NOT-CA-18-109: Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"

Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"

Notice Number: NOT-CA-18-109

Key Dates
Release Date: September 20, 2018

Related Announcements
PAR-18-919
NOT-CA-19-007

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to change the Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)".

The following section has been modified:

Section II. Award Information

Currently reads:

Application Types Allowed

New

Renewal

Resubmission

Revision

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Should correctly read (in italics):

Application Types Allowed

New

Renewal

Resubmission only of PAR-11-150; PAR-14-116; PAR-17-129; or PAR-18-249.

Revision

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Robert J. Nordstrom, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5934
Email: [email protected]

Darrell Tata, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5894
Email: [email protected]